Improving healthcare and medical technology requires a research pipeline that’s decades long. That’s why it’s so important for businesses–which deal by nature in late-stage or ready-for-use technology–to establish and nurture effective partnerships with the laboratories and innovators producing the front-end research their companies and products require to thrive.

MJK Life Science Solutions has tremendous on-the-ground experience identifying and pulling the most promising healthcare-based research out from university labs, through outreach, strategy, guidance, negotiations, and licensing.

You may be a researcher looking to protect and in-license IP resulting from research from your university to start a company; or perhaps you want to out-license the technology to fuel your continued research.  Or you may be the head of a company already, looking to identify, license, and acquire the most cutting-edge, blockbuster-potential early-stage innovations and discoveries from academic labs throughout the world.

In any case, MJK is committed to helping you transfer technology and move research-based IP to the environment where it has the greatest opportunity to advance and thrive both clinically and commercially–moving along the path from bench to bedside, improving healthcare are medical technology, and building successful businesses along the way.

 For more information or to set up an appointment, contact Marc J. Kleinman:  mjk@MJKlifescience.com